Antihypertensive Treatment Improves Microvascular Rarefaction and Reactivity in Low-Risk Hypertensive Individuals

Microcirculation

Volumn 20, Issue 8, 2013, Pages 703-716

  Kaiser, Sérgio E ^a   Sanjuliani, Antonio F ^a   Estato, Vanessa ^b   Gomes, Marilia B ^a   Tibiriçá, Eduardo ^b  

^a STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

Capillary rarefaction; Hypertension; Microvascular dysfunction; Video capillaroscopy

Indexed keywords

HYDROCHLOROTHIAZIDE; METOPROLOL SUCCINATE; OLMESARTAN;

ADULT; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD VESSEL REACTIVITY; CAPILLAROSCOPY; CAPILLARY DENSITY; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG TOLERABILITY; ENDOTHELIAL DYSFUNCTION; FEMALE; FOLLOW UP; HUMAN; HYPEREMIA; HYPERTENSION; LASER DOPPLER FLOWMETRY; LOW RISK POPULATION; MALE; MEDICATION COMPLIANCE; MICROANGIOPATHY; MICROCIRCULATION; MICROIONTOPHORESIS; MICROVASCULAR ENDOTHELIAL CELL; MICROVASCULAR RAREFACTION; OPEN STUDY; OUTPATIENT CARE; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; REST; SINGLE BLIND PROCEDURE; SKIN BLOOD FLOW; SKIN CAPILLARY; TREATMENT RESPONSE; VASODILATATION;

CAPILLARY RAREFACTION; HYPERTENSION; MICROVASCULAR DYSFUNCTION; VIDEO CAPILLAROSCOPY;

ADRENERGIC BETA-1 RECEPTOR ANTAGONISTS; ADULT; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; CAPILLARIES; FEMALE; HUMANS; HYPERTENSION; IMIDAZOLES; MALE; METOPROLOL; MICROCIRCULATION; MIDDLE AGED; SKIN; TETRAZOLES;

EID: 84887174393     PISSN: 10739688     EISSN: 15498719     Source Type: Journal    
DOI: 10.1111/micc.12067     Document Type: Article

References (68)

1. Aellen J, Dabiri A, Heim A, Liaudet L, Burnier M, Ruiz J, Feihl F, Waeber B. Preserved capillary density of dorsal finger skin in treated hypertensive patients with or without type 2 diabetes. Microcirculation 19: 554-562, 2012.
2. Agarwal SC, Allen J, Murray A, Purcell IF. Comparative reproducibility of dermal microvascular blood flow changes in response to acetylcholine iontophoresis, hyperthermia and reactive hyperaemia. Physiol Meas 31: 1-11, 2010.
3. Agarwal SC, Allen J, Murray A, Purcell IF. Laser Doppler assessment of dermal circulatory changes in people with coronary artery disease. Microvasc Res 84: 55-59, 2012.
4. Anderson TJ, Charbonneau F, Title LM, Buithieu J, Rose MS, Conradson H, Hildebrand K, Fung M, Verma S, Lonn EM. Microvascular function predicts cardiovascular events in primary prevention: long-term results from the firefighters and their endothelium (FATE) study. Circulation 123: 163-169, 2011.
5. Antonios TF, Rattray FE, Singer DR, Markandu ND, Mortimer PS, MacGregor GA. Maximization of skin capillaries during intravital video-microscopy in essential hypertension: comparison between venous congestion, reactive hyperaemia and core heat load tests. Clin Sci (Lond) 97: 523-528, 1999.
6. Antonios TF, Rattray FM, Singer DR, Markandu ND, Mortimer PS, MacGregor GA. Rarefaction of skin capillaries in normotensive offspring of individuals with essential hypertension. Heart 89: 175-178, 2003.
7. Antonios TF, Singer DR, Markandu ND, Mortimer PS, MacGregor GA. Rarefaction of skin capillaries in borderline essential hypertension suggests an early structural abnormality. Hypertension 34: 655-658, 1999.
8. Antonios TF, Singer DR, Markandu ND, Mortimer PS, MacGregor GA. Structural skin capillary rarefaction in essential hypertension. Hypertension 33: 998-1001, 1999.
9. Borges JP, Tibirica E, Soares PP, Benedito B, Lima DB, Gomes MB, Farinatti PT. Assessment of vascular function in HIV-infected patients. HIV Clin Trials 12: 215-221, 2011.
10. Chai W, Wang W, Liu J, Barrett EJ, Carey RM, Cao W, Liu Z. Angiotensin II type 1 and type 2 receptors regulate basal skeletal muscle microvascular volume and glucose use. Hypertension 55: 523-530, 2010.
11. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ; National Heart L, Blood Institute Joint National Committee on Prevention DE, Treatment of High Blood P, National High Blood Pressure Education Program Coordinating C. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 Report. JAMA 289: 2560-2572, 2003.
12. Christensen KL, Jespersen LT, Mulvany MJ. Development of blood pressure in spontaneously hypertensive rats after withdrawal of long-term treatment related to vascular structure. J Hypertens 7: 83-90, 1989.
13. Dahlof B, Hansson L. The influence of antihypertensive therapy on the structural arteriolar changes in essential hypertension: different effects of enalapril and hydrochlorothiazide. J Intern Med 234: 271-279, 1993.
14. de Jongh RT, Serne EH, RG IJ, de Vries G, Stehouwer CD. Impaired microvascular function in obesity: implications for obesity-associated microangiopathy, hypertension, and insulin resistance. Circulation 109: 2529-2535, 2004.
15. de Jongh RT, Serne EH, IJzerman RG, Stehouwer CD. Microvascular function: a potential link between salt sensitivity, insulin resistance and hypertension. J Hypertens 25: 1887-1893, 2007.
16. Debbabi H, Bonnin P, Levy BI. Effects of blood pressure control with perindopril/indapamide on the microcirculation in hypertensive patients. Am J Hypertens 23: 1136-1143, 2010.
17. Debbabi H, Uzan L, Mourad JJ, Safar M, Levy BI, Tibirica E. Increased skin capillary density in treated essential hypertensive patients. Am J Hypertens 19: 477-483, 2006.
18. Droog EJ, Henricson J, Nilsson GE, Sjoberg F. A protocol for iontophoresis of acetylcholine and sodium nitroprusside that minimises nonspecific vasodilatory effects. Microvasc Res 67: 197-202, 2004.
19. Farkas K, Kolossvary E, Jarai Z, Nemcsik J, Farsang C. Non-invasive assessment of microvascular endothelial function by laser Doppler flowmetry in patients with essential hypertension. Atherosclerosis 173: 97-102, 2004.
20. Feihl F, Liaudet L, Waeber B, Levy BI. Hypertension: a disease of the microcirculation? Hypertension 48: 1012-1017, 2006.
21. Francischetti EA, Tibirica E, da Silva EG, Rodrigues E, Celoria BM, de Abreu VG. Skin capillary density and microvascular reactivity in obese subjects with and without metabolic syndrome. Microvasc Res 81: 325-330, 2011.
22. Gomes MB, Matheus AS, Tibirica E. Evaluation of microvascular endothelial function in patients with type 1 diabetes using laser-Doppler perfusion monitoring: which method to choose? Microvasc Res 76: 132-133, 2008.
23. He FJ, Marciniak M, Markandu ND, Antonios TF, MacGregor GA. Effect of modest salt reduction on skin capillary rarefaction in white, black, and Asian individuals with mild hypertension. Hypertension 56: 253-259, 2010.
24. Heffernan KS, Suryadevara R, Patvardhan EA, Mooney P, Karas RH, Kuvin JT. Effect of atenolol vs metoprolol succinate on vascular function in patients with hypertension. Clin Cardiol 34: 39-44, 2011.
25. Holowatz LA, Thompson CS, Minson CT, Kenney WL. Mechanisms of acetylcholine-mediated vasodilatation in young and aged human skin. J Physiol 563: 965-973, 2005.
26. Holowatz LA, Thompson-Torgerson CS, Kenney WL. The human cutaneous circulation as a model of generalized microvascular function. J Appl Physiol 105: 370-372, 2008.
27. Ketel IJ, Stehouwer CD, Serne EH, Korsen TJ, Hompes PG, Smulders YM, de Jongh RT, Homburg R, Lambalk CB. Obese but not normal-weight women with polycystic ovary syndrome are characterized by metabolic and microvascular insulin resistance. J Clin Endocrinol Metab 93: 3365-3372, 2008.
28. Koller A, Bagi Z. On the role of mechanosensitive mechanisms eliciting reactive hyperemia. Am J Physiol Heart Circ Physiol 283: H2250-H2259, 2002.
29. Kraemer-Aguiar LG, Maranhao PA, Cyrino FZ, Bouskela E. Waist circumference leads to prolonged microvascular reactive hyperemia response in young overweight/obese women. Microvasc Res 80: 427-432, 2010.
30. Levy BI, Ambrosio G, Pries AR, Struijker-Boudier HA. Microcirculation in hypertension: a new target for treatment? Circulation 104: 735-740, 2001.
31. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, Grassi G, Heagerty AM, Kjeldsen SE, Laurent S, Narkiewicz K, Ruilope L, Rynkiewicz A, Schmieder RE, Struijker Boudier HA, Zanchetti A, Vahanian A, Camm J, De Caterina R, Dean V, Dickstein K, Filippatos G, Funck-Brentano C, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Zamorano JL, Erdine S, Kiowski W, Agabiti-Rosei E, Ambrosioni E, Lindholm LH, Manolis A, Nilsson PM, Redon J, Struijker-Boudier HA, Viigimaa M, Adamopoulos S, Bertomeu V, Clement D, Farsang C, Gaita D, Lip G, Mallion JM, Manolis AJ, O'Brien E, Ponikowski P, Ruschitzka F, Tamargo J, van Zwieten P, Waeber B, Williams B; The task force for the management of arterial hypertension of the European Society of H, The task force for the management of arterial hypertension of the European Society of C. 2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 28: 1462-1536, 2007.
32. Matheus AS, Tibirica E, da Silva PB, de Fatima Bevilacqua da Matta M, Gomes MB. Uric acid levels are associated with microvascular endothelial dysfunction in patients with type 1 diabetes. Diabet Med 28: 1188-1193, 2011.
33. Miura S, Fujino M, Matsuo Y, Tanigawa H, Saku K. Nifedipine-induced vascular endothelial growth factor secretion from coronary smooth muscle cells promotes endothelial tube formation via the kinase insert domain-containing receptor/fetal liver kinase-1/NO pathway. Hypertens Res 28: 147-153, 2005.
34. Mougenot N, Mediani O, Lechat P. Bisoprolol and hydrochlorothiazide effects on cardiovascular remodeling in spontaneously hypertensive rats. Pharmacol Res 51: 359-365, 2005.
35. Nascimento AR, Lessa MA, Sabino B, Bousquet P, Tibirica E. Microvascular effects of centrally acting antihypertensive drugs in spontaneously hypertensive rats. J Cardiovasc Pharmacol 55: 240-247, 2010.
36. Noon JP, Walker BR, Hand MF, Webb DJ. Studies with iontophoretic administration of drugs to human dermal vessels in vivo: cholinergic vasodilatation is mediated by dilator prostanoids rather than nitric oxide. Br J Clin Pharmacol 45: 545-550, 1998.
37. Noon JP, Walker BR, Webb DJ, Shore AC, Holton DW, Edwards HV, Watt GC. Impaired microvascular dilatation and capillary rarefaction in young adults with a predisposition to high blood pressure. J Clin Invest 99: 1873-1879, 1997.
38. Olsen MH, Fossum E, Hoieggen A, Wachtell K, Hjerkinn E, Nesbitt SD, Andersen UB, Phillips RA, Gaboury CL, Ibsen H, Kjeldsen SE, Julius S. Long-term treatment with losartan versus atenolol improves insulin sensitivity in hypertension: ICARUS, a LIFE substudy. J Hypertens 23: 891-898, 2005.
39. Paravicini TM, Touyz RM. NADPH oxidases, reactive oxygen species, and hypertension: clinical implications and therapeutic possibilities. Diabetes Care 31(Suppl 2): S170-S180, 2008.
40. Pasqualini L, Schillaci G, Innocente S, Pucci G, Coscia F, Siepi D, Lupattelli G, Ciuffetti G, Mannarino E. Lifestyle intervention improves microvascular reactivity and increases serum adiponectin in overweight hypertensive patients. Nutr Metab Cardiovasc Dis 20: 87-92, 2010.
41. Penna GL, Garbero Rde F, Neves MF, Oigman W, Bottino DA, Bouskela E. Treatment of essential hypertension does not normalize capillary rarefaction. Clinics 63: 613-618, 2008.
42. Philpott AC, Lonn E, Title LM, Verma S, Buithieu J, Charbonneau F, Anderson TJ. Comparison of new measures of vascular function to flow mediated dilatation as a measure of cardiovascular risk factors. Am J Cardiol 103: 1610-1615, 2009.
43. Pollare T, Lithell H, Selinus I, Berne C. Sensitivity to insulin during treatment with atenolol and metoprolol: a randomised, double blind study of effects on carbohydrate and lipoprotein metabolism in hypertensive patients. BMJ 298: 1152-1157, 1989.
44. Prasad A, Dunnill GS, Mortimer PS, MacGregor GA. Capillary rarefaction in the forearm skin in essential hypertension. J Hypertens 13: 265-268, 1995.
45. Prewitt RL, Chen II, Dowell R. Development of microvascular rarefaction in the spontaneously hypertensive rat. Am J Physiol 243: H243-H251, 1982.
46. Pries AR, Secomb TW, Gaehtgens P. Design principles of vascular beds. Circ Res 77: 1017-1023, 1995.
47. Rizzoni D, Pasini E, Flati V, Rodella LF, Paiardi S, Assanelli D, De Ciuceis C, Porteri E, Boari GE, Rezzani R, Speca S, Favero G, Martinotti S, Toniato E, Platto C, Agabiti-Rosei E. Angiotensin receptor blockers improve insulin signaling and prevent microvascular rarefaction in the skeletal muscle of spontaneously hypertensive rats. J Hypertens 26: 1595-1601, 2008.
48. Rossi M, Bradbury A, Magagna A, Pesce M, Taddei S, Stefanovska A. Investigation of skin vasoreactivity and blood flow oscillations in hypertensive patients: effect of short-term antihypertensive treatment. J Hypertens 29: 1569-1576, 2011.
49. Rossi M, Taddei S, Fabbri A, Tintori G, Credidio L, Virdis A, Ghiadoni L, Salvetti A, Giusti C. Cutaneous vasodilation to acetylcholine in patients with essential hypertension. J Cardiovasc Pharmacol 29: 406-411, 1997.
50. Roustit M, Blaise S, Millet C, Cracowski JL. Reproducibility and methodological issues of skin post-occlusive and thermal hyperemia assessed by single-point laser Doppler flowmetry. Microvasc Res 79: 102-108, 2010.
51. Roustit M, Cracowski JL. Non-invasive assessment of skin microvascular function in humans: an insight into methods. Microcirculation 19: 47-64, 2012.
52. Sabino B, Lessa MA, Nascimento AR, Rodrigues CA, Henriques MG, Garzoni LR, Levy BI, Tibirica E. Effects of antihypertensive drugs on capillary rarefaction in spontaneously hypertensive rats: intravital microscopy and histologic analysis. J Cardiovasc Pharmacol 51: 402-409, 2008.
53. Schiffrin EL. Vascular remodeling in hypertension: mechanisms and treatment. Hypertension 59: 367-374, 2012.
54. Schiffrin EL, Deng LY, Larochelle P. Effects of a beta-blocker or a converting enzyme inhibitor on resistance arteries in essential hypertension. Hypertension 23: 83-91, 1994.
55. Serne EH, Gans RO, ter Maaten JC, Tangelder GJ, Donker AJ, Stehouwer CD. Impaired skin capillary recruitment in essential hypertension is caused by both functional and structural capillary rarefaction. Hypertension 38: 238-242, 2001.
56. Serne EH, Gans RO, ter Maaten JC, ter Wee PM, Donker AJ, Stehouwer CD. Capillary recruitment is impaired in essential hypertension and relates to insulin's metabolic and vascular actions. Cardiovasc Res 49: 161-168, 2001.
57. Seyedi N, Xu X, Nasjletti A, Hintze TH. Coronary kinin generation mediates nitric oxide release after angiotensin receptor stimulation. Hypertension 26: 164-170, 1995.
58. Shamim-Uzzaman QA, Pfenninger D, Kehrer C, Chakrabarti A, Kacirotti N, Rubenfire M, Brook R, Rajagopalan S. Altered cutaneous microvascular responses to reactive hyperaemia in coronary artery disease: a comparative study with conduit vessel responses. Clin Sci (Lond) 103: 267-273, 2002.
59. Sieg-Dobrescu D, Burnier M, Hayoz D, Brunner HR, Waeber B. The return of increased blood pressure after discontinuation of antihypertensive treatment is associated with an impaired post-ischemic skin blood flow response. J Hypertens 19: 1387-1392, 2001.
60. Strain WD, Chaturvedi N, Hughes A, Nihoyannopoulos P, Bulpitt CJ, Rajkumar C, Shore AC. Associations between cardiac target organ damage and microvascular dysfunction: the role of blood pressure. J Hypertens 28: 952-958, 2010.
61. Strauer BE. Significance of coronary circulation in hypertensive heart disease for development and prevention of heart failure. Am J Cardiol 65: 34G-41G, 1990.
62. Thybo NK, Stephens N, Cooper A, Aalkjaer C, Heagerty AM, Mulvany MJ. Effect of antihypertensive treatment on small arteries of patients with previously untreated essential hypertension. Hypertension 25: 474-481, 1995.
63. Tibirica E, Matheus AS, Nunes B, Sperandei S, Gomes MB. Repeatability of the evaluation of systemic microvascular endothelial function using laser Doppler perfusion monitoring: clinical and statistical implications. Clinics (Sao Paulo) 66: 599-605, 2011.
64. Tibirica E, Rodrigues E, Cobas R, Gomes MB. Impairment of skin capillary recruitment precedes chronic complications in patients with type 1 diabetes. Rev Diabet Stud 4: 85-88, 2007.
65. Tibirica E, Rodrigues E, Cobas RA, Gomes MB. Endothelial function in patients with type 1 diabetes evaluated by skin capillary recruitment. Microvasc Res 73: 107-112, 2007.
66. Tropeano AI, Boutouyrie P, Pannier B, Joannides R, Balkestein E, Katsahian S, Laloux B, Thuillez C, Struijker-Boudier H, Laurent S. Brachial pressure-independent reduction in carotid stiffness after long-term angiotensin-converting enzyme inhibition in diabetic hypertensives. Hypertension 48: 80-86, 2006.
67. van der Zijl NJ, Serne EH, Goossens GH, Moors CC, Ijzerman RG, Blaak EE, Diamant M. Valsartan-induced improvement in insulin sensitivity is not paralleled by changes in microvascular function in individuals with impaired glucose metabolism. J Hypertens 29: 1955-1962, 2011.
68. Vuilleumier P, Decosterd D, Maillard M, Burnier M, Hayoz D. Postischemic forearm skin reactive hyperemia is related to cardiovascular risk factors in a healthy female population. J Hypertens 20: 1753-1757, 2002.